Mast cell-derived BH4 and serotonin are critical mediators of postoperative pain
Sci Immunol. 2024 Aug 23;9(98):eadh0545. doi: 10.1126/sciimmunol.adh0545. Epub 2024 Aug 23.
PMID:
Anti-Spike IgG antibodies as correlates of protection against SARS-CoV-2 infection in the pre-Omicron and Omicron era
J Med Virol. 2024 Aug;96(8):e29839. doi: 10.1002/jmv.29839.
PMID:
Dissecting human monoclonal antibody responses from mRNA- and protein-based XBB.1.5 COVID-19 monovalent vaccines
bioRxiv [Preprint]. 2024 Jul 16:2024.07.15.602781. doi: 10.1101/2024.07.15.602781.
PMID:
SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023
Nat Commun. 2024 Jul 11;15(1):5847. doi: 10.1038/s41467-024-50052-2.
PMID:
Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles
Front Immunol. 2024 Jun 10;15:1425842. doi: 10.3389/fimmu.2024.1425842. eCollection 2024.
PMID:
Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase
mBio. 2024 Jul 17;15(7):e0108524. doi: 10.1128/mbio.01085-24. Epub 2024 Jun 20.
PMID:
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland
Respiration. 2024;103(9):593-600. doi: 10.1159/000539410. Epub 2024 May 29.
PMID:
Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City
J Virol. 2024 Jun 13;98(6):e0062624. doi: 10.1128/jvi.00626-24. Epub 2024 May 15.
PMID:
Humoral correlates of protection against influenza A H3N2 virus infection
J Infect Dis. 2024 Dec 16;230(6):1319-1328. doi: 10.1093/infdis/jiae258.
PMID:
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
J Clin Invest. 2024 May 1;134(9):e176640. doi: 10.1172/JCI176640.
PMID: